Cardiometabolic disease, cognitive decline, and brain structure in middle and older age
Authors:
Open Access
- 9 April 2024
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Vol. 16 (2) , e12566
Abstract
INTRODUCTION: The presence of multiple cardiometabolic diseases (CMDs) has been linked to increased dementia risk, but the combined influence of CMDs on cognition and brain structure across the life course is unclear.METHODS: In the UK Biobank, 46,562 dementia‐free participants completed a cognitive test battery at baseline and a follow‐up visit 9 years later, at which point 39,306 also underwent brain magnetic resonance imaging. CMDs (diabetes, heart disease, and stroke) were ascertained from medical records. Data were analyzed using age‐stratified (middle age [< 60] versus older [≥ 60]) mixed‐effects models and linear regression.RESULTS: A higher number of CMDs was associated with significantly steeper global cognitive decline in older (β = –0.008; 95% confidence interval: −0.012, −0.005) but not middle age. Additionally, the presence of multiple CMDs was related to smaller total brain volume, gray matter volume, white matter volume, and hippocampal volume and larger white matter hyperintensity volume, even in middle age.DISCUSSION: CMDs are associated with cognitive decline in older age and poorer brain structural health beginning already in middle age.Highlights: We explored the association of CMDs with cognitive decline and brain MRI measures. CMDs accelerated cognitive decline in older (≥60y) but not middle (<60) age. CMDs were associated with poorer brain MRI parameters in both middle and older age. Results highlight the connection between CMDs and cognitive/brain aging.Keywords
Funding Information
- Vetenskapsrådet (2021‐01647)
- Alzheimerfonden
- Demensfonden
This publication has 41 references indexed in Scilit:
- Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General PopulationAmerican Journal of Epidemiology, 2017
- Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and EuropeThe Lancet Public Health, 2017
- Multimodal population brain imaging in the UK Biobank prospective epidemiological studyNature Neuroscience, 2016
- Cognitive Test Scores in UK Biobank: Data Reduction in 480,416 Participants and Longitudinal Stability in 20,346 ParticipantsPLOS ONE, 2016
- Association of Cardiometabolic Multimorbidity With MortalityJAMA, 2015
- UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old AgePLOS Medicine, 2015
- A major role for cardiovascular burden in age-related cognitive declineNature Reviews Cardiology, 2015
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationThe Lancet Neurology, 2013
- Revising the definition of Alzheimer's disease: a new lexiconThe Lancet Neurology, 2010
- Late‐Life Body Mass Index and Dementia Incidence: Nine‐Year Follow‐Up Data from the Kungsholmen ProjectJournal of the American Geriatrics Society, 2007